Neurotrophic and anhidrotic keratopathy treated with substance P and insulin like growth factor 1

被引：87
|
作者：
Brown, SM
Lamberts, DW
Reid, TW
Nishida, T
Murphy, CJ
机构：
[1] Department of Ophthalmology, Thompson Hall, Texas Tech Univ. Hlth. Sci. Center, Lubbock
来源：
ARCHIVES OF OPHTHALMOLOGY | 1997年 / 115卷 / 07期
关键词：
D O I：
10.1001/archopht.1997.01100160096021
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
[No abstract available]
引用
收藏
页码：926 / 927
页数：2
相关论文
共 50 条
  • [1] Persistent Epithelial Defects Due to Neurotrophic Keratopathy Treated with a Substance P-Derived Peptide and Insulin-Like Growth Factor 1
    Teruo Nishida
    Tai-ichiro Chikama
    Naoyuki Morishige
    Ryoji Yanai
    Naoyuki Yamada
    Jun Saito
    Japanese Journal of Ophthalmology, 2007, 51 : 442 - 447
  • [2] Persistent epithelial defects due to neurotrophic keratopathy treated with a substance P-derived peptide and insulin-like growth factor 1
    Nishida, Teruo
    Chikama, Tai-ichiro
    Morishige, Naoyuki
    Yanai, Ryoji
    Yamada, Naoyuki
    Saito, Jun
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2007, 51 (06) : 442 - 447
  • [3] Treatment of neurotrophic keratopathy with substance-P-derived peptide (FGLM) and insulin-like growth factor I
    Chikama, T
    Fukuda, K
    Morishige, N
    Nishida, T
    LANCET, 1998, 351 (9118): : 1783 - 1784
  • [4] Substance P- and Insulin-like Growth Factor 1-derived Tetrapeptides for Neurotrophic Keratopathy Related to Leprosy: A Clinical Trial
    Kondo, Shoko
    Okano, Yoshiko
    Iraha, Satoshi
    Tokunaga, Shoji
    OPHTHALMOLOGY SCIENCE, 2025, 5 (02):
  • [5] Efficacy of substance P and insulin-like growth factor-1 peptides for preventing postsurgical superficial punctate keratopathy in diabetic patients
    Chikamoto, Nobuhiko
    Chikama, Tai-ichiro
    Yamada, Naoyuki
    Nishida, Teruo
    Ishimitsu, Tadashi
    Kamiya, Akira
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2009, 53 (05) : 464 - 469
  • [6] Efficacy of substance P and insulin-like growth factor-1 peptides for preventing postsurgical superficial punctate keratopathy in diabetic patients
    Nobuhiko Chikamoto
    Tai-ichiro Chikama
    Naoyuki Yamada
    Teruo Nishida
    Tadashi Ishimitsu
    Akira Kamiya
    Japanese Journal of Ophthalmology, 2009, 53 : 464 - 469
  • [7] Open clinical study of eye-drops containing tetrapeptides derived from substance P and insulin-like growth factor-1 for treatment of persistent corneal epithelial defects associated with neurotrophic keratopathy
    Yamada, N.
    Matsuda, R.
    Morishige, N.
    Yanai, R.
    Chikama, T-I
    Nishida, T.
    Ishimitsu, T.
    Kamiya, A.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2008, 92 (07) : 896 - 900
  • [8] Efficacy of Recombinant Human Nerve Growth Factor in Stage 1 Neurotrophic Keratopathy
    Yavuz Saricay, Leyla
    Bayraktutar, Betul N.
    Lilley, Jonathan
    Mah, Francis S.
    Massaro-giordano, Mina
    Hamrah, Pedram
    OPHTHALMOLOGY, 2022, 129 (12) : 1448 - 1450
  • [9] Synergistic effects of substance P with insulin-like growth factor-1 on epithelial migration of the cornea
    Nishida, T
    Nakamura, M
    Ofuji, K
    Reid, TW
    Mannis, MJ
    Murphy, CJ
    JOURNAL OF CELLULAR PHYSIOLOGY, 1996, 169 (01) : 159 - 166
  • [10] The effect of substance P with insulin-like growth factor-1 on corneal epithelial cell proliferation
    Katakami, C
    Hara, R
    Yamamoto, H
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S100 - S100
12345